Table 1

Summary of prognostic factors for relapse incidence, survival, and leukemia-free survival identified in the multivariate analysis

VariableOSRRLFS
HR95% CIPHR95% CIPHR95% CIP
Age* 1.771 1.287-2.436 <.001 1.147 0.779-1.69 NS 1.482 1.047-2.089 .027 
WBC 1.429 1.021-2.0 .038 1.22 0.779-1.910 NS 1.032 0.71-1.499 NS 
FLT3 (ITD vs wild type) 1.854 1.315-2.614 <.001 2.395 1.569-3.654 .000051 1.76 1.169-2.59 .004 
NPM1 (mut vs wild type) 0.676 0.484-0.944 .022 0.542 0.352-0.835 .0054 0.739 0.512-1.067 NS 
NPM1mut/FLT3wt 0.601 0.422-0.858 .005 0.488 0.313-0.76 .0015 0.615 0.418-0.905 .014 
FLT3-ITD ratio§ 1.274 1.124-1.444 <.001 1.604 1.427-1.8 2 × 10−15 1.363 1.162-1.598 <.001 
VariableOSRRLFS
HR95% CIPHR95% CIPHR95% CIP
Age* 1.771 1.287-2.436 <.001 1.147 0.779-1.69 NS 1.482 1.047-2.089 .027 
WBC 1.429 1.021-2.0 .038 1.22 0.779-1.910 NS 1.032 0.71-1.499 NS 
FLT3 (ITD vs wild type) 1.854 1.315-2.614 <.001 2.395 1.569-3.654 .000051 1.76 1.169-2.59 .004 
NPM1 (mut vs wild type) 0.676 0.484-0.944 .022 0.542 0.352-0.835 .0054 0.739 0.512-1.067 NS 
NPM1mut/FLT3wt 0.601 0.422-0.858 .005 0.488 0.313-0.76 .0015 0.615 0.418-0.905 .014 
FLT3-ITD ratio§ 1.274 1.124-1.444 <.001 1.604 1.427-1.8 2 × 10−15 1.363 1.162-1.598 <.001 

All variables analyzed for all reported outcomes (response to induction, OS, RR, and LFS) are described in the text. HR, hazard ratio; NS, not significant; 95% CI, 95% confidence interval.

*

Below and above the median value: 47 years old.

Below and above the median: 19.9 × 109/L.

NPM1mut/FLT3wt genotype vs all other possibilities.

§

Considered as a continuous variable.

or Create an Account

Close Modal
Close Modal